Page last updated: 2024-10-23

aspirin and Hemangioma Thrombocytopenia Syndrome

aspirin has been researched along with Hemangioma Thrombocytopenia Syndrome in 5 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"KHE can be an unusual cause of hydrops fetalis; in such cases, diagnosis can be challenging since generalized edema can obscure KHE."1.46Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis. ( Beléndez-Bieler, C; Bernardo-Atienza, B; Campos-Domínguez, M; Franco-Fernández, ML; Gregorio-Hernández, R; Huerta-Aragonés, J; Lancharro-Zapata, Á; Sánchez-Luna, M; Sobrino-Fernández, E, 2017)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sobrino-Fernández, E1
Campos-Domínguez, M1
Gregorio-Hernández, R1
Huerta-Aragonés, J1
Beléndez-Bieler, C1
Lancharro-Zapata, Á1
Franco-Fernández, ML1
Bernardo-Atienza, B1
Sánchez-Luna, M1
MacFarland, SP1
Sullivan, LM1
States, LJ1
Bailey, LC1
Balamuth, NJ1
Womer, RB1
Olson, TS1
Fernandez-Pineda, I2
Lopez-Gutierrez, JC2
Chocarro, G1
Bernabeu-Wittel, J1
Ramirez-Villar, GL1
Korsaga-Somé, N1
Maruani, A1
Abdo, I1
Favrais, G1
Lorette, G1
Ramirez, G1
Marquez, C1

Trials

1 trial available for aspirin and Hemangioma Thrombocytopenia Syndrome

ArticleYear
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Child, Preschool; Ecchymosis; Female; Follo

2013

Other Studies

4 other studies available for aspirin and Hemangioma Thrombocytopenia Syndrome

ArticleYear
Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.
    Pediatric dermatology, 2017, Volume: 34, Issue:3

    Topics: Administration, Oral; Aspirin; Cesarean Section; Diagnosis, Differential; Drug Therapy, Combination;

2017
Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:4

    Topics: Aspirin; Child; Hemangioendothelioma; Humans; Kasabach-Merritt Syndrome; Male; Sarcoma, Kaposi; Siro

2018
[Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
    Annales de dermatologie et de venereologie, 2015, Volume: 142, Issue:10

    Topics: Aspirin; Axilla; Combined Modality Therapy; Compression Bandages; Disease Progression; Disseminated

2015
Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Disseminated Intravascular Coagulation; Fem

2010